XML 54 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
COMMITMENTS AND CONTINGENCIES (Tables)
12 Months Ended
Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Contingent Consideration
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the year ended December 31, 2018 and 2017 is as follows (in thousands):
 
 
Contingent Consideration Liabilities Related to Acquisition of Derma Sciences (See Note 4)
 
Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc.
 
Location in Financial Statements
 
 
Short-term
 
Long-term
 
Short-term
 
Long-term
 
 
Balance as of January 1, 2017
 

 

 

 
22,036

 
 
Additions from acquisition of Derma Sciences
 
33,707

 
3,467

 

 

 
 
Transfers from long-term to current portion
 
2,193

 
(2,193
)
 
22,184

 
(22,184
)
 
 
Payments
 
(31,346
)
 

 

 

 
 
(Gain)/Loss from change in fair value of contingent consideration liabilities
 
(4,239
)
 
113

 
294

 
148

 
Selling, general and administrative
Balance as of December 31, 2017
 
$
315

 
$
1,387

 
$
22,478

 
$

 
 
Transfers from long-term to current portion
 
1,387

 
(1,387
)
 
$

 
$

 
 
Payments
 
(2,000
)
 

 
$
(24,000
)
 
$

 
 
Loss from change in fair value of contingent consideration liabilities
 
298

 
230

 
$
1,522

 
$

 
Selling, general and administrative
Balance as of December 31, 2018
 
$

 
$
230

 
$

 
$

 
 
A reconciliation of the opening balances to the closing balances of these Level 3 measurements is as follows (in thousands):
 
Supply Agreement Liability
 
Above Market Supply Agreement Liability
 
Location in Statement of Operations
 
Short-term
 
Long-term
 
Short-term
 
Long-term
 
 
Balance as of January 1, 2017
166

 

 

 
2,648

 
 
Payments
(166
)
 

 
(113
)
 
(415
)
 
 
Transfer

 

 
3,273

 
(3,273
)
 
 
(Gain)/loss from change in fair value

 

 
(519
)
 
1,040

 
Selling, general and administrative
Balance as of December 31, 2017
$

 
$

 
$
2,641

 
$

 
 
Payments
$

 
$

 
$
(1,817
)
 
$

 
 
(Gain)/loss from change in fair value
$

 
$

 
$
(470
)
 
$

 
Selling, general and administrative
Transfer to accounts payable
$

 
$

 
$
(159
)
 
$

 
 
Balance as of December 31, 2018
$

 
$

 
$
195

 
$